Skip to main content
Log in

The colony stimulating factors

  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

Hematopoiesis is a dynamic process, which generate in the range of 109 cells/kg each day of erythroid and myeloid ceils respectively.In vitro assays that were developed 20 years ago, have been used to define factors that can stimulate growth and differentiation of bone marrow (BM) derived progenitor cells. These growth factors for hematopoiesis were termed Colony Stimulating Factors (CSFs) since the assay system was to induce colonies. With the application of molecular biologic approaches, the genes encoding for these CSFs have been localized and cloned. Production of CSFs and other soluble signal substances (cytokines) as pure proteins have led to important insights into how hematopoiesis is regulated by a complex network made up by interactions between ceils and cytokines. The availability of CSFs in clinically useful amounts has also led to clinical trials with new strategies for treating hematopoietic dysfunctions, congenital or acquired. Because others have recently reviewed clinical applications or basic science studies on the colony stimulating factors, we will summarize the two with focus on common features between the different CSFs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Plutznik D H, Sachs L: The cloning of normal “mast” cells in tissue culture.J Cell Physio1 66, 319 (1965).

    Article  Google Scholar 

  2. Bradley T R, Metcalf D: The growth of mouse bone marrow cellsin vitro.Aust J Exp Biol Med Sci 44, 287 (1966)

    Article  CAS  PubMed  Google Scholar 

  3. Stanley E R, Gullbert L F: Methods of purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).Jlmmunol Meth 42, 253 (1981).

    Article  CAS  Google Scholar 

  4. Robinson B E, Quesenberry P J: Hematopoietic growth factors.Am J Med Sci 300, 163–170, 237–244, 311–321 (1990).

    Article  CAS  PubMed  Google Scholar 

  5. Metcalf D: The colony stimulating factors; Discovery development and clinical applications.Cancer 65, 2185 (1990).

    Article  CAS  PubMed  Google Scholar 

  6. Gasson J C: Molecular Physiology of Granulocyte-Macrophage Colony stimulating factor (rev).Blood 77(6), 1131 (1991).

    CAS  PubMed  Google Scholar 

  7. Grosh W W, Quesenberry P J: Recombinant Human Hematopoietic Growth factors in the treatment of cytopenias.Clin lmmunol Immunopathol 62(1), 25 (1992).

    Article  Google Scholar 

  8. Moore M A S: Clinical Implications of positive and negative hematopietic Stern Cell Regulators.Blood 78(1), 1 (1991).

    CAS  PubMed  Google Scholar 

  9. Zsebo K M, Wypych J, McNiece I K Lu H S, Smith K A, Karkare S B, Sachdev R K Yuschenkoff V N, Birkett N C, Williams L R, Satyagai V N, Tung W, Bosselman R A, Mendiaz E A, Langley K E: Identification, purification of hematopoieitc stem cell factor from buffalo rat liver-conditioned medium.Cell 63, 195 (1990).

    Article  CAS  PubMed  Google Scholar 

  10. Williams D E, Eisenman J, Baird A, Rauch C, Van Ness K, March C J, Park L S, Martin U, Mochizuki D Y, Boswell H S, Burgess G S, Cosman D, Lyman S D: Identification of a ligand for the c-kit proto-oncogene.Cell 63, 167 (1990).

    Article  CAS  PubMed  Google Scholar 

  11. Haylock D N, To L B, Dowse T L, Juttner C A, Simmons P J: Exvivo Expansion and Maturation of Peripheral Blood CD34+ Cells Into the Myeloid Lineage.Blood 80(6), 1405 (1992).

    CAS  PubMed  Google Scholar 

  12. Lansdorp P M, Dragowska W: Long-Term Erythro-poiesis from Constant Numbers of CD34+ Cells in Serum-free Cultures Initiated with Highly Purified Progenitor Cells from Human Bone Marrow.JExp Med 175, 1501 (1992).

    Article  CAS  Google Scholar 

  13. Yokota T, Coffman R L, Hagiwara H, Rennick DM, Takebe Y, Yokoto K Gemmel L, Shrader B, Yang G, Meyerson P, Luh J, Hoy P, Pene J, Briere F, Spits H, Banchereau J, de Vries J, Lee F D, Arai N, Arai K-I: Isolation and characterization of lymphokines cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony stimulating factor activities: relationship to IL-5.Proc Natl Acad Sci 84, 7388 (1987).

    Article  CAS  PubMed  Google Scholar 

  14. Moore M A S: The clinical use of Colony Stimulating Factors.Ann Rev Immunol 9, 159 (1991).

    Article  CAS  Google Scholar 

  15. Dower S K Smith C A, Parl L S: Human Cytokine receptors.J Clin lmmunot 10(6), 289 (1990).

    Article  CAS  Google Scholar 

  16. Olsson I, Gullberg U, LantzM, Richter J: The receptors for regulatory molecules of hematopoiesis.EurJHaemato 148, 1 (1992).

    Google Scholar 

  17. Bazan J F: Structural design and molecular evolution of a cytokine receptor superfamily.Proc Natl Acad Sci USA 87, 6934 (1990).

    Article  CAS  PubMed  Google Scholar 

  18. Sherr C J: Colony stimulating factor-1 receptor.Blood 75, 1 (1990).

    CAS  PubMed  Google Scholar 

  19. Majumder S, ’Brown K, Qiu F-H, Besmer P: e-kit protein, a transmembrane kinase: identification in tissues and characterization.Mol CeUBiol 8, 4896 (1988).

    CAS  Google Scholar 

  20. Civin C I, Strauss L C, Brovall C, Fackler M J, Schwartz J F, Shaper J H: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-lacells.J lmmunol 133, 157 (1984).

    CAS  Google Scholar 

  21. Brandt J E, Baird N, Lu L, Srour E, Hoffman R: Characterization of a human progenitor cell capable of forming blast cell containing coloniesin vitro.J Clin Invest 82, 1017 (1988).

    Article  CAS  PubMed  Google Scholar 

  22. Andrew R G, Singer J W, Bernstein I D: Precursors of colony forming cells in humans can be distinguished from colony forming cells by expression of the CD33 and CD34 antigens and fight scatter properties.J Exp Med 169, 1721 (1989).

    Article  Google Scholar 

  23. Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-termin vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.J Exp Med 172, 509 (1990).

    Article  CAS  PubMed  Google Scholar 

  24. Bender J G, Unverzagt K L, Walker D E, Lee W, Van Epps D E, Smith D H, Stewart C C, To L B: Identification and Comparison of CD34-Positive Cells and Their Subpoputations from Normal Peripheral Blood and Bone Marrow Using Multicolor Flow Cytometry.Blood 77(12), 2591 (1991).

    CAS  PubMed  Google Scholar 

  25. Zsebo K M, Williams D A, Geisser EN, Broudy V C, Martin F H, Atkins H L, Hsu R-Y, Birkett N C, Okino K H, Murdock D C, Jacobsen F W, Langley K E, Smith K A, Takeishi T, Cattanach B M, Galli S J, Suggs S V: Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.Cell 63, 213 (1990).

    Article  CAS  PubMed  Google Scholar 

  26. Witte O N: Steel locus defines new multipotent growth factor.Cell 63, 5 (1990).

    Article  CAS  PubMed  Google Scholar 

  27. Chabot B, Stephenson D A, Chapman V M, Besmer P, Bernstein A: The proto-onc gene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.Nature 335, 88 (1988).

    Article  CAS  PubMed  Google Scholar 

  28. Le Beau M M, Westbrock C A, Diaz M O, Larson R A, Rowley J D, Gasson J C, Golde D W, Sherr C J: Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.Science 231, 984 (1986)

    Article  PubMed  Google Scholar 

  29. van Leeuwen B H, Martinson M E, Webb G C, Young I G: Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5 and GM-CSF genes on human chromosome 5.Blood 73, 1142 (1989).

    PubMed  Google Scholar 

  30. Nimer S D, Golde D W: The 5q- abnormality.Blood 70, 1705 (1987).

    CAS  PubMed  Google Scholar 

  31. Le Beau M M, Lemons R S, Espinosa R III, Larson R A, Aral N, Rowley J D: Interleukin-4 and Interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q),Blood 73, 647 (1989).

    PubMed  Google Scholar 

  32. Thomas J A, Lee D J, Kidd P, Rubin E, Kaufmann J, Bonnem E M, Fefer A: Subcutaneous granulocyte-macrophage colony stimulating factors in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematological effects.J Clin Oncol 7, 629 (1989).

    Google Scholar 

  33. Vadhan-Raj S, Keating M, LeMaistre A, Hittleman W N, McCreadie K, Trujillo J M, Broxmeyer H E, Henney C, Gutterman J U: Effects of recombinant human granulocytemacrophage colony-stimulating factor in patients with myelodysplastic syndromes.N Engl J Med 317, 1545 (1987).

    CAS  PubMed  Google Scholar 

  34. Hammond W P, Price T H, Souza L M, Dale D C: Treatment of cycfic neutropenia with granulocyte Colony stimulating Factor.N Engl J Med 320, 1306 (1989).

    PubMed  Google Scholar 

  35. Bonilla M A, Gillio A P, Ruggerio M, Kernan N A, Brochstein J A, Abboud M A, Fumagalli L, Vincent M, Welte K, Souza L M, O’ Reilly R J: Effects of recombinant human granulocyte colony stimulating factor on neutropenia in patients with congenital agranulocytosis.N Engl JMed 320, 1574 (1989).

    CAS  Google Scholar 

  36. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni A M: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor.Blood 74, 1905 (1989).

    CAS  PubMed  Google Scholar 

  37. Björldaolm M: Aplastic anaemia: pathogenetic mechanisms and treatment with special reference to immunomodulation.J lnt Med 231, 575 (1992).

    Google Scholar 

  38. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Höcker P, Huber C, Kahls P, Knapp W, Köller U, Lechner K, Volc-Ptatzer B: Further evidence for lymphokine overproduction in severe aplastic anemia.Blood 72, 266 (1988).

    CAS  PubMed  Google Scholar 

  39. Antin J H, Smith B R, Holmes W, Rosenthal D S: PhaseI/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.Blood 72, 705 (1988).

    CAS  PubMed  Google Scholar 

  40. Negrin R S, Heuber D H, Nagler A: Treatment ofmyelodysplastic syndromes with recombinant human granulocyte colony stimulating factor: A Phase I-II trial.Ann lnt Med 110, 979 (1989).

    Google Scholar 

  41. Salmon S, Liu R: Effects of GM-CSF inin vitro growth of human solid tumors.J Clin Oncol 7,1346 (1989).

    CAS  PubMed  Google Scholar 

  42. Bronchud M H, Scarffe J H, Thatcher N: Phase I/lI study of recombinant human G-CSF in patients receiving intensive chemotherapy for small cell lung cancer.Br J Cancer 56, 809 (1987).

    CAS  PubMed  Google Scholar 

  43. Gabrilove J, Jakubowski A, Scher H, Steinberg C, Wong G, Grous J, Yagoda A, Fain K, Moore M, Clarcson B: Effect of granulocyte-macrophage colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium.N Engl J Med 318, 1414 (1988).

    CAS  PubMed  Google Scholar 

  44. Crawford J, Ozer H, Johnson D, and the G-CSF Study group: Granulocyte colony stimulating factor: Prevention of chemotherapy-induced febrile neutropenia in patients with small cell cancer. A randomized double blind placebo controlled trial.Proc Am Soc Clin Oncol 9, 229 (1990).

    Google Scholar 

  45. Link H, Boogaerts M, Carella A, Ferrant A, Gadner H, Gorin N: Recombinant human granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for acute lymphoblastic leukemia and non-Hodgkins’s lymphoma: A randomized double blind, multicenter trial in Europe.Blood 76, 152a (1990).

    Google Scholar 

  46. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of Peripheral Blood Progenitor cells by Sequential Administration of IL-3 and Granulocyte-Macrophage Colony-Stimulating Factor Following Polychemotherapy With Etoposide Ifosfamide and Cisplatin.Blood 79, 1193 (1992).

    CAS  PubMed  Google Scholar 

  47. Kessinger A, Armitage J O: The evolving role of Autologous Peripheral stem cells Transplantation Following High Dose Therapy for Malignancies (Editorial).Blood 77, 211 (1991).

    CAS  PubMed  Google Scholar 

  48. Kessinger A, Axmitage J O, Smith D M, Landmark J D, Bierman P J, Wiesenburger D D: High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.Blood 74, 1260 (1989).

    CAS  PubMed  Google Scholar 

  49. Reiffers J, Castaigne S, “lilly H, Lepage E, Leverger G, Henon P, Douay L: Hematopoietic reconsfitution after autologous stem cell transplantation: A report of 46 cases.Plasma Ther Transfis Technol 8, 360 (1987).

    Article  Google Scholar 

  50. Haas R, Ho A D, Bredthauer U, Cayeaux S, Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. ExpHematol 18, 94 (1990).

    CAS  PubMed  Google Scholar 

  51. Gianrti A M, Bregni M, Siena S, Villa S, Sciorelli G A, Ravagnani F, Pellegris G, Bonadonna G: Rapid and complete hemopoietic reconstitution following combine transplantation of autologous blood and bone marrow cells. A changing role for high-dose chemotherapy ?Hematol Oncol 7, 139 (1989).

    Article  Google Scholar 

  52. Dinarello C A: Anti-cytokine strategies.Eur Cytokine Netw 3, 7 (1992).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hansson, M., Söderström, T. The colony stimulating factors. Med Oncol. & Tumor Pharmacother. 10, 5–12 (1993). https://doi.org/10.1007/BF02987762

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02987762

Keywords

Navigation